logo
Morgan Stanley Sticks to Their Sell Rating for Sims (SMUPF)

Morgan Stanley Sticks to Their Sell Rating for Sims (SMUPF)

In a report released today, Julianna Sick from Morgan Stanley maintained a Sell rating on Sims, with a price target of A$13.00. The company's shares closed last Tuesday at $9.94.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Currently, the analyst consensus on Sims is a Moderate Sell with an average price target of $9.49, which is a -4.53% downside from current levels. In a report released yesterday, Jefferies also maintained a Sell rating on the stock with a A$12.00 price target.
The company has a one-year high of $10.41 and a one-year low of $6.42. Currently, Sims has an average volume of 150.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Top analyst resets Nvidia price target for one surprising reason before earnings
Top analyst resets Nvidia price target for one surprising reason before earnings

Miami Herald

time2 hours ago

  • Miami Herald

Top analyst resets Nvidia price target for one surprising reason before earnings

Nvidia (NVDA) stock just got a major price target reset ahead of earnings, but the twist isn't more AI hype. KeyBanc Capital Markets John Vinh's call is built around a factor effectively hiding in plain sight, something investors haven't fully priced in. It's not about demand, nor is it about China, or even the usual AI narrative. Don't miss the move: Subscribe to TheStreet's free daily newsletter Instead, it's a potential shift that could change how quickly Nvidia is able to ramp up sales, while fattening up its margins in the process. Moreover, with expectations sky-high already, this quiet revamp could be an overlooked driver, making Nvidia's Q2 earnings print one to watch more closely. John Vinh, managing director and equity research analyst at KeyBanc Capital Markets, has a keen eye on the chip space and AI-infrastructure supply chains. Among the stocks he covers closely is Nvidia, along with other chip names, and he has become a trusted voice on the sector. On TipRanks, he attracts a 5-star rating, with an impressive 60% success rate and an 18.9% average return per rating. This makes him one of the top-ranked tech analysts tracked on the platform. For perspective, Dan Ives of Wedbush fame has just a 49% success rate on the platform. Ahead of Nvidia's Q2 earnings report on August 27, KeyBanc's John Vinh lifted his Nvidia price target to $215 from $190, on the back of better manufacturing yields. Specifically, Vinh cites the GB200 server rack yields nearing an incredible 85%, which means that more systems are breezing through QA and shipping faster. Related: Cathie Wood drops $21.6 million on biotech stock That improved throughput has him raising his full-year rack shipment forecast to 30,000 units, up from 25,000. Simply put, Nvidia's backlog is being converted into sales at a much quicker pace, on the back of more efficient execution at the factory level. Supply is catching up, too. Blackwell B200 availability has surged at an eye-catching 40% in Q2, and it's set to climb another 20% in Q3. The rollout of Blackwell Ultra is also accelerating, potentially making up 50% of Blackwell shipments by October, resulting in a more diverse product mix. On numbers, Vinh now sees Q2 sales at $47.1 billion (consensus estimate at $45.7 billion) but trims Q3 to $50.4 billion (consensus estimate at $53.5 billion), excluding China due to license uncertainty. If we include China, he sees even greater upside of $2 billion to $3 billion, driven by H20 and RTX6000D (B40) shipments. Nvidia dominates the AI hardware stack with a whopping 80% market share, covering chips, systems, networking, and sticky CUDA software. That grip naturally shows up in its financials. Nvidia posted $130.5 billion in FY2025 sales, more than 50% from last year, with U.S. hyperscalers deploying millions of accelerators in training and running their AI models. Blackwell is a big part of that impressive lead. Nvidia's new Blackwell B200/GB200 platform is a beast, packing 208 billion transistors, a fresh Transformer Engine, and NVLink "super-highways" that let 576 GPUs act like one giant brain. Related: Top tech stock analyst revamps AI 'buy' list The result is that it efficiently delivers 30-times quicker inference and much speedier AI responses, like almost instantaneous chatbot replies. Memory is another massive leap. Blackwell uses HBM3e (High Bandwidth Memory 3e special stacked DRAM right next to a potent processor for ultra-fast data access), handling up to 288GB per GPU. Analysts feel Blackwell could contribute 80% of Nvidia's high-end shipments in 2025, while Nvidia is set to control north of 70% of HBM supply. Nvidia is set to report its fiscal year 2026 Q2 results Aug. 27, and here's what Wall Street expects: Revenue: $45.7 billion to $45.9 billion (management guided for around $45 billion in sales)EPS: Roughly $1Gross margin: 71.8% (marker); 5-year average is 66.2%. The big swing factors? The first is Data Center momentum, which has been massive over the past several quarters, particularly at $39.1 billion in Q1. Second, there's the early Blackwell ramp with more B200 chips flowing in and GB200 racks passing quality checks a lot quicker, pulling revenue forward. Related: Billionaire fund manager doubles down on Nvidia, partner in AI stack shift Finally, there's the plumbing, where networking gear like NVLink switches and full racks are moving abroad with memory (HBM) and packaging bottlenecks. Wall Street models expect Nvidia to beat Q2 numbers, where some see Q2 revenue hitting closer to $47 billion, but Q3 staying near $50 billion to $52 billion, depending on geopolitics. Investors shouldn't expect a clean boost from China in Nvidia's guidance just yet. The U.S. only started issuing H20 licenses on August 8, and reports surfaced from Beijing, where it discouraged its use for sensitive work. Meanwhile, Nvidia is cooking up a more robust Blackwell-based "B30A," but still needs customer testing and volume. More News: Billionaire George Soros supercharges Nvidia stake, loads up on AI playsTesla just got its biggest break yet in the robotaxi wars with a key permitBank of America drops shocking price target on hot weight-loss stock post-earnings On top of that, Washington is weighing a 15% revenue-share tax on China's AI-chip sales from Nvidia and AMD. According to White House press secretary Karoline Leavitt, despite the hurdles, the Commerce Department is still focused on getting the deal done. Related: Legendary fund manager Stanley Druckenmiller buys $133 million of under-radar AI stock The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

U.S. Tariffs on India Could Backfire, Putting Apple (AAPL) and Tech Giants at Risk
U.S. Tariffs on India Could Backfire, Putting Apple (AAPL) and Tech Giants at Risk

Business Insider

time2 hours ago

  • Business Insider

U.S. Tariffs on India Could Backfire, Putting Apple (AAPL) and Tech Giants at Risk

Columbia University economist Jeffrey Sachs has warned that recent U.S. tariffs on India could backfire. Speaking on the Breaking Points show, Sachs said the move has pushed India closer to China and helped strengthen BRICS (Brazil, Russia, India, China, and South Africa) against American interests. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Sachs called the tariffs 'the stupidest tactical move in US foreign policy' and argued they were more about politics than strategy. He singled out South Carolina Senator Lindsey Graham for criticism, describing him as a poor voice on trade. Sachs also dismissed former Trump trade adviser Peter Navarro as unqualified, despite his Harvard degree. Impact on BRICS Unity The tariffs include a 25% penalty on Indian purchases of Russian oil. According to Sachs, the measure had the opposite of its intended effect. Rather than isolating Russia, it brought BRICS members into closer coordination. He noted that within two days of the announcement, leaders from BRICS countries were on calls working more closely together. China, which buys more Russian oil than India, was not targeted by similar tariffs. This uneven approach drew criticism from former U.S. officials as well. John Bolton, who served as Trump's National Security Adviser, called the move a mistake that weakened trust with India. Tariffs Put Trade, Tech, and Defense at Risk Beyond trade, Sachs warned of long-term damage to relations. The U.S. has spent years building ties with India as part of its Asia strategy. However, he argued the tariffs risk undoing that progress. Sachs said India now views the U.S. as unreliable, regardless of whether the penalties are lifted. If U.S.-India ties continue to weaken, the impact could spread across industries on both sides. Apple (AAPL) may face higher costs for its India-based manufacturing, while Microsoft (MSFT), Google (GOOG), and Amazon (AMZN) could see pressure on their Indian hubs that rely on local talent. Also at risk are Indian exporters in textiles, gems, jewelry, auto parts, and foodstuffs face tariffs on goods worth $48.2 billion. At the same time, defense and technology cooperation between firms such as Lockheed Martin (LMT), Boeing (BA), and Indian defense groups could lose momentum if trust erodes. These risks threaten supply chains, exports, and investment across the $200 billion trade relationship. The warning comes as US policy focuses on countering China's influence in Asia. If ties with India continue to sour, analysts suggest Washington may face a key question: who lost India? Using TipRanks' Comparison Tool, we've brought together all the stocks mentioned in this piece, giving investors a clear view of how each company stacks up and how the industries compare overall.

CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls
CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls

Yahoo

time2 hours ago

  • Yahoo

CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The 5 Upgrades: Morgan Stanley upgraded HP Enterprise (HPE) to Overweight from Equal Weight with a price target of $28, up from $22. The firm believes accretion from the Juniper acquisition and multiple upside is not being priced into the shares. H.C. Wainwright upgraded CoreWeave (CRWV) to Buy from Neutral with an $180 price target. The stock's valuation "has sunk deep enough," the analyst tells investors in a research note. Arete also upgraded CoreWeave to Buy from Neutral with an $180 price target. Citi upgraded Bio-Techne (TECH) to Buy from Neutral with a price target of $70, up from $55. The firm views the company's growth and margin outlook as conservative and believes the stock is undervalued at current levels. Jefferies upgraded Enphase Energy (ENPH) to Hold from Underperform with a price target of $36, up from $28. Treasury guidance issued on Friday of last week was positive for residential solar, yet Enphase's stock is up just about 10%, notes the analyst, who perceives a market disconnect in which the buyside gives little credit for TPO sales, wrongly assuming the majority of sales are tied instead to cash/loan. UBS upgraded iQiyi (IQ) to Buy from Neutral with a price target of $3.32, up from $1.97. iQiyi's fundamentals could be bottoming out amid a more benign regulatory environment, the analyst tells investors in a research 5 Downgrades: Wedbush downgraded Instacart (CART) to Underperform from Neutral with a price target of $42, down from $55, arguing that Amazon's (AMZN) expansion of its same-day perishable grocery delivery service has intensified competition. Citi downgraded Coty (COTY) to Neutral from Buy with a price target of $4.25, down from $6.50. The company's fiscal Q4 results came in weaker than expected despite a low bar, the analyst tells investors in a research note. Wells Fargo downgraded Truist Financial (TFC) to Equal Weight from Overweight with an unchanged $47 price target after its announced 5-year strategic plan that contains "new new metrics." The company is lagging its numerous peers with this announcement after years of share loss and weak JD Power rankings, the analyst tells investors in a research note. JPMorgan downgraded Alcon (ALC) to Neutral from Overweight with a price target of $77.53, down from $105.88. The company reported another "soft" quarter and cut to guidance, the analyst tells investors in a research note. BofA downgraded (MNDY) to Neutral from Buy with a price target of $205, down from $240. Search engine optimization driven website visits to sank by an average of 23.5% year-over-year in Q2 and declines accelerated to 25.3% in July, according to Similarweb data, reports the analyst. Top 5 Initiations: Argus initiated coverage of DexCom (DXCM) with a Buy rating and $100 price target. The firm sees the company maintaining above industry average growth with expanding customer reach across the continuous glucose monitoring for diabetes landscape and leveraging costs to enhance profitability. Morgan Stanley assumed coverage of NetApp (NTAP) with an Equal Weight rating and price target of $115, up from $106. The firm says its intra-quarter storage channel checks were most cautious for NetApp. Rosenblatt initiated coverage of PubMatic (PUBM) with a Buy rating and $17 price target. The company's Q2 earnings report unearthed a second problem in a major DSP relationship, setting the stage for a decline in adjusted EBITDA in 2026, but these operating challenges seem likely to be overcome, the analyst tells investors in a research note. BofA initiated coverage of NuScale Power (SMR) with a Neutral rating and $36 price target. The developer of small modular reactor nuclear technology's use of lightwater technology and LEU, rather than scarce HALEU, offers "a more de-risked fuel pathway" than peers, but the firm's Neutral rating reflects the early commercialization stage, a lack of binding contracts, and a valuation that "already prices in significant future success." Morgan Stanley initiated coverage of Trevi Therapeutics (TRVI) with an Overweight rating and $18 price target. The firm sees a multi-billion dollar opportunity for Haduvio. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store